Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson’s disease ; volume:21 ; number:1 ; day:28 ; month:9 ; year:2024 ; pages:1-19 ; date:12.2024
Journal of neuroinflammation ; 21, Heft 1 (28.9.2024), 1-19, 12.2024
- Creator
-
Yao, Hongkai
Tong, Weifang
Song, Yunping
Li, Ruoyu
Xiang, Xuerui
Cheng, Wen
Zhou, Yunjiao
He, Yijing
Yang, Yi
Liu, Yunxi
Li, Siguang
Jin, Lingjing
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-024-03234-0
- URN
-
urn:nbn:de:101:1-2412142105300.901351988811
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yao, Hongkai
- Tong, Weifang
- Song, Yunping
- Li, Ruoyu
- Xiang, Xuerui
- Cheng, Wen
- Zhou, Yunjiao
- He, Yijing
- Yang, Yi
- Liu, Yunxi
- Li, Siguang
- Jin, Lingjing
- SpringerLink (Online service)
Other Objects (12)
Mitochondrial glutamine transporter SLC1A5_var, a potential target to suppress astrocyte reactivity in Parkinson’s Disease
Parkinson
Parkinson
Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Polysorbate 80 surface modified SLNs of formoterol suppress SNCA gene and mitochondrial oxidative stress in mice model of Parkinson’s disease
The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort
Parkinson, Teil 2.. Leben mit fortschreitendem Parkinson
Mitochondrial glutamine transporter SLC1A5_var, a potential target to suppress astrocyte reactivity in Parkinson’s Disease
Parkinson
Parkinson
Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Polysorbate 80 surface modified SLNs of formoterol suppress SNCA gene and mitochondrial oxidative stress in mice model of Parkinson’s disease
The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort
Parkinson, Teil 2.. Leben mit fortschreitendem Parkinson
Mitochondrial glutamine transporter SLC1A5_var, a potential target to suppress astrocyte reactivity in Parkinson’s Disease
Parkinson
Parkinson
Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Polysorbate 80 surface modified SLNs of formoterol suppress SNCA gene and mitochondrial oxidative stress in mice model of Parkinson’s disease
The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort